-
Canagliflozin: Interpreting a Negative mTOR Screen
2026-09-12
Canagliflozin hemihydrate is best understood not only as an SGLT2 research tool, but also as a useful negative-control boundary in pathway screening. This article connects renal glucose reabsorption inhibition with a 2025 drug-sensitized yeast study to show how negative mTOR results can improve assay interpretation.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Guide
2026-09-12
Use EZ Cap™ Cy5 EGFP mRNA (5-moUTP) to separate cellular uptake from productive translation in one experiment. Its Cy5 signal supports delivery and trafficking measurements, while EGFP reports functional expression across lipid, nanoparticle, and electroporation workflows.
-
Calnexin Shapes CFTR Variant Rescue
2026-09-11
Tedman et al. used deep mutational scanning to show that calnexin controls CFTR surface expression and corrector responsiveness in a variant- and domain-dependent manner. The study provides a framework for interpreting why the F508del mutation and other clinical CFTR variants differ in pharmacological rescue, while highlighting the need to measure proteostasis and channel function separately.
-
Ceftolozane Sulfate: PK/PD Research Workflows
2026-09-11
Build a translational workflow around Ceftolozane sulfate, from MIC determination and time-kill testing to neutropenic mouse studies and PK/PD modeling. The approach emphasizes AmpC-stable activity, isolate-specific exposure targets, and troubleshooting for resistant Pseudomonas aeruginosa assays.
-
CasKAS: Genome-Wide CRISPR Specificity by ssDNA Mapping
2026-09-10
CasKAS introduces a direct chemical strategy for profiling genome-wide CRISPR binding and cleavage by mapping the single-stranded DNA exposed when sgRNA-loaded Cas9 engages a target. The method extends to both active Cas9 and catalytically inactive dCas9, providing a comparatively accessible way to study off-target specificity in vitro and in cells.
-
T-5224 for AP-1-Driven Inflammation Research
2026-09-10
T-5224 is a selective C-Fos/AP-1 inhibitor for connecting transcription-factor activity with inflammatory, osteoclastogenic, and ferroptosis-related readouts. This practical guide covers model selection, dosing controls, mechanistic validation, and troubleshooting across arthritis research and emerging oncology applications.
-
Bifidobacterium and FMT in Hepatic Encephalopathy
2026-09-09
This 2025 European Journal of Neuroscience study used [18F]PBR146 micro-PET/CT to compare Bifidobacterium and fecal microbiota transplantation in rats with bile duct ligation-induced chronic hepatic encephalopathy. Regional imaging suggested a neuroinflammatory benefit from Bifidobacterium, whereas fecal microbiota transplantation produced no clear positive effect, highlighting the value of spatially resolved molecular imaging for gut-targeted interventions.
-
RIPA Lysis Buffer for EV–Cancer Signaling Workflows
2026-09-09
RIPA Lysis Buffer (Medium) supports reproducible protein extraction from cultured cells and tissue while preserving many degradation- and phosphorylation-sensitive readouts. This workflow translates extracellular-vesicle cancer biology into practical Western blot, immunoprecipitation, ELISA, and signaling-assay sample preparation.
-
Carvedilol: From Receptor Blockade to HCT Strategy
2026-09-08
Carvedilol is more than a cardiovascular research tool. As a β-adrenergic receptor antagonist with α1-adrenergic activity, antioxidant effects, and vascular anti-proliferative properties, it can reveal how sympathetic signaling shapes tissue repair. New transplant findings make receptor selectivity, assay context, and post-HCT timing essential considerations for translational researchers.
-
Carbapenemase Gene Transmission in CREC, Guangdong
2026-09-08
Chen et al. integrated resistance phenotyping, gene-localization assays, conjugation experiments, mobile-element analysis, and ERIC-PCR to characterize carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major transmission concern and shows why resistance surveillance must distinguish clonal spread from horizontal gene transfer.
-
Designing Better RNA Readouts for Translation
2026-09-07
A thought-leadership guide to using Firefly Luciferase mRNA as a mechanistically informed reporter for delivery development, gene expression assays, cell viability studies, and in vivo imaging. The article connects cap and nucleotide engineering with emerging lipid nanoparticle strategies, while defining the evidence boundaries between assay validation and translational claims.
-
Cotton Dirigent Proteins Redirect Terpenoid Defense
2026-09-05
This Nature Communications study identifies two cotton dirigent proteins as extracellular gatekeepers that redirect hemigossypol metabolism toward hemigossypolone and heliocides in green organs. Genetic, biochemical, metabolite, and biotic-stress evidence shows that this compartment-specific pathway strengthens defense against diverse pathogens and herbivores.
-
Baicalein Workflows for Cancer and Inflammation
2026-09-05
Build reproducible 12-LOX, viability, and apoptosis experiments with Baicalein while controlling solvent, precipitation, and assay-interference risks. A reference-informed workflow also shows how to test pathway modulation without assuming that findings for another flavonoid translate directly.
-
Magneto-Piezoelectric Scaffolds for Infectious Bone Repair
2026-09-04
This ACS Nano study develops a dual-responsive, 3D-printed scaffold that combines magnetic biofilm disruption with ultrasound-mediated activation of Icam1+ macrophages. Its central mechanistic finding is that macrophage oxidative phosphorylation and pro-reparative activity can be enhanced through JAK2–STAT3 activation while suppressing MAPK–JNK signaling, providing a coordinated strategy for infection control and bone regeneration.
-
Gramine, CUL3–MTDH, and Ferroptosis in TNBC
2026-09-04
A 2026 study identifies a CUL3–MTDH regulatory axis through which gramine suppresses triple-negative breast cancer by promoting ferroptosis. Its combination of target-engagement assays, ferroptosis rescue, MTDH knockdown, and xenograft validation provides a mechanistic framework for evaluating gramine and related natural compounds in TNBC research.